Literature DB >> 17331567

Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.

Krystyna Pawlak1, Dariusz Pawlak, Michal Mysliwiec.   

Abstract

INTRODUCTION: The disturbances of haemostasis and enhanced oxidative stress (SOX) appear to contribute to the cardiovascular disease (CVD) in hemodialysis (HD) patients. The aim of the present study was to investigate if the disorders of coagulation/fibrinolysis system are associated with the presence of CVD in these patients.
MATERIALS AND METHODS: We compared pre-dialysis levels of uPA, suPAR, tissue factor (TF) and its inhibitor (TFPI), prothrombin fragment F1+2 (F1+2); a marker of SOX-Cu/Zn superoxide dismutase (Cu/Zn SOD) and a surrogate of inflammation-high sensitivity C-reactive protein (hs CRP) in HD patients with and without CVD.
RESULTS: The uPA/suPAR system and hs CRP values were significantly greater in patients with CVD than in those without CVD; whereas TF, TFPI, F1+2 and Cu/Zn SOD levels were comparable in both patient groups. TF was positively correlated with both uPA (p<0.001) and suPAR levels (p<0.05). Logistic regression analysis showed that elevated levels of suPAR, TF and uPA were independently associated with the presence of CVD in HD patients.
CONCLUSIONS: The association between TF and uPA/suPAR system is significantly related to the presence of CVD in HD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331567     DOI: 10.1016/j.thromres.2007.01.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Soluble urokinase plasminogen activator receptor (suPAR) is associated with metabolic changes in HIV-1-infected Africans: a prospective study.

Authors:  Carla M T Fourie; Johannes M Van Rooyen; Annamarie Kruger; Michael H Olsen; Jesper Eugen-Olsen; Rudolph Schutte; Aletta E Schutte
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  A novel signaling pathway: fibroblast nicotinic receptor alpha1 binds urokinase and promotes renal fibrosis.

Authors:  Guoqiang Zhang; Kelly A Kernan; Alison Thomas; Sarah Collins; Yumei Song; Ling Li; Weizhong Zhu; Renee C Leboeuf; Allison A Eddy
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

3.  Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.

Authors:  Carlos R Franco Palacios; John C Lieske; Hani M Wadei; Andrew D Rule; Fernando C Fervenza; Nikolay Voskoboev; Vesna D Garovic; Ladan Zand; Mark D Stegall; Fernando G Cosio; Hatem Amer
Journal:  Transplantation       Date:  2013-08-27       Impact factor: 4.939

4.  The effects of citrate dialysate in hemodialysis on polymorphonuclear elastase interaction with tissue factor and its inhibitor.

Authors:  Jiameng Li; Si Sun; Mei Han; Liya Wang; Ruoxi Liao; Yuqin Xiong; Yupei Li; Heng Jiang; Zheng Qin; Anil Maharjan; Mario Cozzolino; Alexander Zarbock; Baihai Su
Journal:  Ann Transl Med       Date:  2019-08

5.  Haemodiafiltration elicits less platelet activation compared to haemodialysis.

Authors:  Gergely Becs; Renáta Hudák; Zsolt Fejes; Ildikó Beke Debreceni; Harjit Pal Bhattoa; József Balla; János Kappelmayer
Journal:  BMC Nephrol       Date:  2016-10-13       Impact factor: 2.388

6.  Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.

Authors:  Tomasz W Kamiński; Krystyna Pawlak; Małgorzata Karbowska; Michał Myśliwiec; Dariusz Pawlak
Journal:  BMC Nephrol       Date:  2017-01-25       Impact factor: 2.388

7.  Vascular Structure and Inflammation in a South African Population: The SABPA Study.

Authors:  Carla Swart; Leandi Lammertyn; Paul I Welsh; Shani Botha-Le Roux
Journal:  Pulse (Basel)       Date:  2019-07-10

8.  Elevation of Platelet and Monocyte Activity Markers of Atherosclerosis in Haemodialysis Patients Compared to Peritoneal Dialysis Patients.

Authors:  Ksenija Stach; Susanne Karb; Ibrahim Akin; Martin Borggrefe; Bernhard Krämer; Thorsten Kälsch; Anna-Isabelle Kälsch
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

Review 9.  Thrombolome and Its Emerging Role in Chronic Kidney Diseases.

Authors:  Justyna Fryc; Beata Naumnik
Journal:  Toxins (Basel)       Date:  2021-03-18       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.